AMD Archives - Insight

MDFA responds after NSW health chief says eye checks can be deferred

Myles Hume — Thu, 22 Jul 2021 21:23:06 +0000

Sydney recorded 124 cases on 22 July, with lockdowns expected to be extended.

NSW chief health officer Dr Kerry Chant’s use of eye appointments as an example of activities that can be deferred during the lockdown has prompted the Macular Disease Foundation Australia (MDFA) to
Read More

The post MDFA responds after NSW health chief says eye checks can be deferred appeared first on Insight.

Optometrists back Aussie-developed AI system

Myles Hume — Tue, 18 May 2021 21:26:16 +0000

Eyetelligence Assure has regulatory approvals in Australia, New Zealand, Europe and the UK.

Australian optometrists are reporting positive results with a homegrown clinical decision support tool that uses artificial intelligence (AI) to analyse retinal images for features of the major blinding
Read More

The post Optometrists back Aussie-developed AI system appeared first on Insight.

Ophthalmology’s most life-changing procedures revealed

Myles Hume — Mon, 22 Feb 2021 01:01:38 +0000

Longer wait times for public cataract surgery are prompting people to seek private cover.

Seventy-five percent of ophthalmic interventions investigated in a major study have shown evidence of improving quality of life for patients with eye disease, with cataract surgery and anti-VEGF therapy
Read More

The post Ophthalmology’s most life-changing procedures revealed appeared first on Insight.

RANZCO updates AMD referral pathway for optometrists

Myles Hume — Tue, 01 Dec 2020 20:27:37 +0000

Prof Robyn Guymer helped develop the first AMD referral pathway, released in 2016.

Professor Robyn Guymer has led an expert panel to update RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management, which accounts for greater accessibility to retinal imaging equipment
Read More

The post RANZCO updates AMD referral pathway for optometrists appeared first on Insight.

AI-driven headset that detects AMD set for Australian debut

Myles Hume — Tue, 01 Sep 2020 21:04:48 +0000

The headset requires no dark-room and features an artificial intelligence-driven onboard technician.

A US company that has incorporated dark adaptometry into a new wearable headset for age-related macular degeneration (AMD) is on the cusp of introducing the AI-guided technology to the Australian ophthalmic
Read More

The post AI-driven headset that detects AMD set for Australian debut appeared first on Insight.

Aussie firm reveals next-gen MIGS device in pipeline

Myles Hume — Mon, 31 Aug 2020 21:40:12 +0000

The company's sales growth has been driven by its iTrack MIGS device.

Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for
Read More

The post Aussie firm reveals next-gen MIGS device in pipeline appeared first on Insight.

Study: AMD patients at higher risk of COVID-19 death

Myles Hume — Tue, 11 Aug 2020 00:25:05 +0000

AMD is a proxy for complement-activation disorders, which may influence the severity of COVID-19.

A new study has found that people with age-related macular degeneration (AMD) are at greater risk of developing severe complications and dying from COVID-19. The association between the eye disorder and
Read More

The post Study: AMD patients at higher risk of COVID-19 death appeared first on Insight.

Telehealth to continue gathering pace post-pandemic

Staff Writer — Mon, 04 May 2020 03:37:52 +0000

Associate Professor Peter van Wijngaarden says innovation comes to the fore in times of crisis.

Rapid uptake of telehealth services amid the COVID-19 pandemic is energising research focused on new ways to remotely diagnose and monitor eye disease, according to one of Australia’s top-ranked eye
Read More

The post Telehealth to continue gathering pace post-pandemic appeared first on Insight.

Patients gambling with vision due to COVID confusion

Myles Hume — Mon, 06 Apr 2020 06:55:27 +0000

The prevalence of poor vision in people living with dementia ranges from 20 to 50%, according to a new study.

Uncertainty surrounding the COVID-19 lockdown measures has led to a major spike in missed appointments for macular disease treatment, sparking concern that thousands of Australians are putting their vision
Read More

The post Patients gambling with vision due to COVID confusion appeared first on Insight.

Protein in blood a direct link to AMD

Myles Hume — Thu, 19 Mar 2020 23:02:58 +0000

Scientists have identified a new protein that could help establish improved diagnosis and treatment of age-related macular degeneration (AMD). The research team from the UK report that
Read More

The post Protein in blood a direct link to AMD appeared first on Insight.